
On Tuesday, Swiss Sonova, the world’s biggest hearing aid manufacturer, released its figures for the financial year 2021/2022, surpassing analysts’ estimations for the firm’s sales in particular.
Still, Sonovas’s solid performance isn’t likely to have an impact on the stocks of other industry players, including GN Hearing and Demant, according to Sydbank Senior Equity Analyst Søren Løntoft Hansen.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app